John Richard is Co-Founder and Chief Business Officer for Mereo BioPharma plc, a publicly-traded biopharmaceutical company founded in 2015. Mr. Richard previously served in various roles, including Director and Operating Partner, with Phase4 Partners, a life science investment firm. Mr. Richard was also a partner with Georgia Venture Partners, a seed venture capital firm focused on the biotechnology industry. Earlier in his career he headed business development for the public companies SEQUUS Pharmaceuticals, VIVUS, and Genome Therapeutics.
Mr. Richard received his M.B.A. from the Harvard Business School and a B.S. from Stanford University.
